We are live on ! Find out more
SRC

Sage Rhino Capital Portfolio holdings

AUM $617M
1-Year Est. Return 28.74%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+28.74%
3 Year Est. Return
+86.8%
5 Year Est. Return
+76.14%
10 Year Est. Return
AUM
$315M
AUM Growth
+$65.7M
Cap. Flow
+$50.5M
Cap. Flow %
16.04%
Top 10 Hldgs %
33.39%
Holding
218
New
28
Increased
100
Reduced
58
Closed
7
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
76
ExxonMobil
XOM
$634B
$818K 0.26%
7,414
+761
+11% +$81.5K
MS icon
77
Morgan Stanley
MS
$340B
$803K 0.26%
9,439
+40
+0.4% +$3.41K
TWLO icon
78
Twilio
TWLO
$36.6B
$784K 0.25%
16,011
+15
+0.1% +$854
PFF icon
79
iShares Preferred and Income Securities ETF
PFF
$13.3B
$777K 0.25%
25,450
+9,299
+58% +$289K
LLY icon
80
Eli Lilly
LLY
$1.06T
$773K 0.25%
2,114
-19
-0.9% -$6.74K
CCJ icon
81
Cameco
CCJ
$42.4B
$760K 0.24%
33,541
+751
+2% +$17.7K
ETB
82
Eaton Vance Tax-Managed Buy-Write Income Fund
ETB
$458M
$745K 0.24%
56,625
+7,600
+16% +$108K
AXP icon
83
American Express
AXP
$230B
$739K 0.23%
4,999
+67
+1% +$9.93K
SHEL icon
84
Shell
SHEL
$245B
$736K 0.23%
12,916
+349
+3% +$19.2K
DFAX icon
85
Dimensional World ex US Core Equity 2 ETF
DFAX
$12.4B
$732K 0.23%
33,867
-11,496
-25% -$239K
JPST icon
86
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
$729K 0.23%
+14,549
New +$729K
UNH icon
87
UnitedHealth
UNH
$370B
$727K 0.23%
1,372
-1
-0.1% -$530
V icon
88
Visa
V
$677B
$724K 0.23%
3,485
+72
+2% +$14.5K
AZN icon
89
AstraZeneca
AZN
$250B
$720K 0.23%
5,312
-183
-3% -$22.9K
BRK.B icon
90
Berkshire Hathaway Class B
BRK.B
$1.13T
$703K 0.22%
2,277
+2
+0.1% +$594
VIG icon
91
Vanguard Dividend Appreciation ETF
VIG
$114B
$701K 0.22%
4,615
CF icon
92
CF Industries
CF
$17.3B
$680K 0.22%
7,980
+66
+0.8% +$6.7K
CMCSA icon
93
Comcast
CMCSA
$90B
$678K 0.22%
19,389
-1,397
-7% -$46.2K
COST icon
94
Costco
COST
$420B
$662K 0.21%
1,450
-1
-0.1% -$489
ASML icon
95
ASML
ASML
$669B
$650K 0.21%
1,190
+102
+9% +$53.4K
VXF icon
96
Vanguard Extended Market ETF
VXF
$31.7B
$644K 0.2%
4,848
-75
-2% -$10.2K
CVX icon
97
Chevron
CVX
$366B
$630K 0.2%
3,510
+31
+0.9% +$5.41K
NVS icon
98
Novartis
NVS
$297B
$617K 0.2%
6,803
+399
+6% +$33.6K
NFLX icon
99
Netflix
NFLX
$309B
$607K 0.19%
20,580
+570
+3% +$16K
CNXC icon
100
Concentrix
CNXC
$1.57B
$605K 0.19%
4,547
+196
+5% +$23.8K

Similar funds

Sage Rhino Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Sage Rhino Capital held 218 positions worth $315M, up 26% from $249M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Sage Rhino Capital deployed $50.5M of net new capital in Q4 2022, opening 28 new positions and adding to 100 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 155,962 shares worth $7.83M.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, down from 9.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Short-Term Inflation-Protected Securities Index Fund, an estimated $4.61M trimmed.

  • Sage Rhino Capital's largest Q4 2022 buy was Avantis US Large Cap Value ETF: 155,962 shares worth $7.83M.
  • Sage Rhino Capital added most to Vanguard Total Bond Market in Q4 2022, an estimated $3.81M increase.
  • Sage Rhino Capital's biggest Q4 2022 reduction was Vanguard Short-Term Inflation-Protected Securities Index Fund, cutting an estimated $4.61M.
  • Sage Rhino Capital fully exited Vanguard Global ex-US Real Estate ETF in Q4 2022, selling an estimated $1.05M.
  • Sage Rhino Capital's ten largest holdings make up 33% of its $315M portfolio in Q4 2022.
  • Sage Rhino Capital opened 28 new positions and closed 7 in Q4 2022.
  • Sage Rhino Capital's portfolio value rose 26% quarter-over-quarter to $315M.

Based on Sage Rhino Capital's 13F filing for Q4 2022, filed 1 Feb 2023.